Skip to Main Content

Author Details

Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
2009
25
15
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37490493Evaluating the utility of brightfield image data for mechanism of action prediction.PLoS Comput Biol2023
34392603Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.Mol Oncol2022
36062323New regulators of the tetracycline-inducible gene expression system identified by chemical and genetic screens.FEBS Open Bio2022
34033645A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors.PLoS Biol2021
31285544The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity.Cell Death Differ2020
32005748Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.Clin Cancer Res2020
32605631High content drug screening for Fanconi anemia therapeutics.Orphanet J Rare Dis2020
30527999A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats.Cell Chem Biol2019
29413322Human NUDT22 Is a UDP-Glucose/Galactose Hydrolase Exhibiting a Unique Structural Fold.Structure2018
29142246A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family.Nat Commun2017
28447629Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.Nature2017
26987120PopulationProfiler: A Tool for Population Analysis and Visualization of Image-Based Cell Screening Data.PLoS One2016
26507796Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies.FEBS J2016
26862114Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition.Cancer Res2016
25789582Processing of protein ADP-ribosylation by Nudix hydrolases.Biochem J2015
25624349The E3 ubiquitin ligase ARIH1 protects against genotoxic stress by initiating a 4EHP-mediated mRNA translation arrest.Mol Cell Biol2015
24695224MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.Nature2014
23354688Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.Sci Signal2013
22490379Combining doublecortin-like kinase silencing and vinca alkaloids results in a synergistic apoptotic effect in neuroblastoma cells.J Pharmacol Exp Ther2012
21433042Diclofenac inhibits tumor necrosis factor-α-induced nuclear factor-κB activation causing synergistic hepatocyte apoptosis.Hepatology2011
22006019Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.Mol Cell Biol2011
20228126Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cells.Endocr Relat Cancer2010
20521231High-throughput live cell imaging of apoptosis.Curr Protoc Cell Biol2010
19158362Cross-talk between integrins and oncogenes modulates chemosensitivity.Mol Pharmacol2009
19895272The cancer stem cell microenvironment and anti-cancer therapy.Int J Radiat Biol2009
  • 1 - 25 of 25

Recommended Authors

College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Mitchell Cancer Institute, University of South Alabama
Career Start Year 2008
Number of shared co-authors 0
Arc Institute
Career Start Year 2007
Number of shared co-authors 0
Duke University
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2003
Number of shared co-authors 1
College of Medicine, University of Saskatchewan
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, Comprehensive Cancer Centre, Medical University of Vienna
Career Start Year 2002
Number of shared co-authors 2
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Stanford University Medical Center
Career Start Year 1997
Number of shared co-authors 0
University of Toronto
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Broad Institute of Harvard and MIT
Career Start Year 1993
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year 1987
Number of shared co-authors 0
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 1
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 0
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 0
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 0

Collaborators

The University of Sheffield
Co-authored papers 9
Karolinska Institute
Co-authored papers 8
Karolinska Institutet
Co-authored papers 6
Stockholm University
Co-authored papers 5
Karolinska Institutet
Co-authored papers 4
Stockholm University
Co-authored papers 4
Stockholm University
Co-authored papers 3
Umea University
Co-authored papers 3
Uppsala University
Co-authored papers 2
Department of Pharmacy, Uppsala University
Co-authored papers 2
Uppsala University
Co-authored papers 2
Karolinska Institutet
Co-authored papers 2
Stockholm University
Co-authored papers 2
Co-authored papers 1
Faculty of Pharmacy, University of Seville
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Uppsala University
Co-authored papers 1
Uppsala University
Co-authored papers 1
University of Ljubljana
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Stockholm University
Co-authored papers 1
Division of Clinical Genetics, Lund University
Co-authored papers 1
Max Planck Institute for Biology of Ageing
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Stockholm University
Co-authored papers 1
Stanford University
Co-authored papers 1
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 1
Amsterdam University Medical Centers location AMC
Co-authored papers 1